HuagongsheHuagongshe Chemie-Druckbericht · Nur für Forschungszwecke
HCID 5325Erstellt: 26. Oktober 2026
Sulfamerazin
SMI · Sulphamerazine · A-310 · rp2632 · DEBENAL · 2643-RP · Mebacid · Mesulfa
https://huagongshe.com/de/chemical/5325
Identifikatoren & physikalische Daten
| CAS No. | 127-79-7 |
|---|
| Summenformel | C11H12N4O2S |
|---|
| Durchschnittliche Molmasse | 264,31 g/mol |
|---|
| Monoisotopische Masse | 264,06809662 g/mol |
|---|
| SMILES | Cc1ccnc(NS(=O)(=O)c2ccc(N)cc2)n1 |
|---|
| InChIKey | QPPBRPIAZZHUNT-UHFFFAOYSA-N |
|---|
| PubChem CID | 5325 |
|---|
| ChEMBL | CHEMBL438 |
|---|
| ChEBI | CHEBI:102130 |
|---|
| EC No. | 204-866-2 |
|---|
| DTXSID | DTXSID0023612 |
|---|
| Lokaler Name | Sulfamerazin |
|---|
Chemische & physikalische Eigenschaften
| XLogP | 0,1 |
|---|
| Polarare Oberfläche (TPSA) | 106 |
|---|
| H-Brücken-Donoren | 2 |
|---|
| H-Brücken-Akzeptoren | 6 |
|---|
| Frei drehbare Bindungen | 3 |
|---|
| Schwere Atome | 18 |
|---|
| Formalladung | 0 |
|---|
| Komplexität | 360 |
|---|
| Arzneimittel | Pharmaceuticals -> Listed in ZINC15Pharmaceuticals -> AntibioticsPharmaceuticals -> Antibiotics (Sulfonamide) |
|---|
| SpringerMaterials Properties | Fusion temperature |
|---|
| LogP (Verteilungskoeffizient) | 0.14 |
|---|
| Löslichkeit | 3.04e-01 g/LDMSO (Slightly), Methanol (Slightly)202mg/L(20 ºC) |
|---|
| Human Drugs | FDA approved drugs -> Active ingredient |
|---|
| Animal Drugs | Active Ingredients (Sulfamerazine) -> FDA GreenbookPharmaceuticals -> Animal Drugs -> Approved in Taiwan |
|---|
| Schmelzpunkt | 236 °C234-238°C |
|---|
| Physical Description | Solid |
|---|
| Collision Cross Section | 156.3 Ų [M+H]+ [CCS Type: TWMethod: calibrated with polyalanine and drug standards]154.8 Ų [M+H]+ [CCS Type: TW]168.3 Ų [M+Na]+ [CCS Type: TWMethod: calibrated with Waters Major Mix]155.14 Ų [M+H]+ [CCS Type: TW161.33 Ų [M-H]- |
|---|
| Siedepunkt | 519.1±52.0 °C(Predicted) |
|---|
| Dichte | 1.3364 (rough estimate) |
|---|
| Brechungsindex | 1.6440 (estimate) |
|---|
| Lagerbedingungen | 2-8°C |
|---|
| Aggregatzustand | Solid |
|---|
| pKa (Säurekonstante) | pKa 2.29(H2O t = 24.0 I = 0.5 (NaCl)) (Uncertain) |
|---|
| Farbe | White to Off-White |
|---|
| Merck | 14,8913 |
|---|
| BRN | 249133 |
|---|
| InChI | 1S/C11H12N4O2S/c1-8-6-7-13-11(14-8)15-18(16,17)10-4-2-9(12)3-5-10/h2-7H,12H2,1H3,(H,13,14,15) |
|---|
| InChIKey | QPPBRPIAZZHUNT-UHFFFAOYSA-N |
|---|
| SMILES | Cc1ccnc(NS(=O)(=O)c2ccc(N)cc2)n1 |
|---|
| CAS Datenbank | 127-79-7(CAS DataBase Reference) |
|---|
| NIST chemische Informationen | Sulfamerazine(127-79-7) |
|---|
| EPA chemische Informationen | Benzenesulfonamide, 4-amino-N-(4-methyl-2-pyrimidinyl)- (127-79-7) |
|---|
Sicherheit & Vorschriften
| GHS-Einstufung | This chemical does not meet GHS hazard criteria for 2% (1 of 51) of reports.WarningH315 (94.1%): Causes skin irritation [Warning Skin corrosion/irritation]P261, P264, P264+P265, P271, P280, P302+P352, P304+P340, P305+P351+P338, P319, P321, P332+P317, P337+P317, P362+P364, P403+P233, P405, and P501 (click each P-code to see the statement)Aggregated GHS information provided per 51 reports by companies from 10 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies. |
|---|
| Regulatorische Informationen | Sulfamerazine: Does not have an individual approval but may be used as a component in a product covered by a group standard. It is not approved for use as a chemical in its own right. |
|---|
| Weitere Sicherheitsinformationen | IMAP assessments - Benzenesulfonamide, 4-amino-N-(4-methyl-2-pyrimidinyl)-: Human health tier I assessment |
|---|
| Hazard Classes and Categories | Skin Irrit. 2 (94.1%) |
|---|
| F | 10 |
|---|
| Wassergefährdungsklasse (WGK) | 2 |
|---|
| TSCA-Inventar-Status | TSCA listed |
|---|
| Zollcode | 2935904000 |
|---|
| RTECS-Nr. | WP0750000 |
|---|
| R-Sätze (R) | 36/37/38 |
|---|
| Toxizität | LD50 oral in mouse: 25gm/kg |
|---|
| Gefahrensymbole | Xi |
|---|
| Sicherheitshinweise (S) | 26-36/37 |
|---|
| Lagerklasse | 11 - Combustible Solids |
|---|
| Gefahrenklasse | Acute Tox. 4 Oral |
|---|